Ono Pharmaceutical Co., Ltd. (FRA:ON4)

Ono Pharmaceutical Statistics

Total Valuation

FRA:ON4 has a market cap or net worth of EUR 5.54 billion. The enterprise value is 5.29 billion.

Market Cap	5.54B
Enterprise Value	5.29B

Important Dates

The next estimated earnings date is Monday, February 2, 2026.

Earnings Date	Feb 2, 2026
Ex-Dividend Date	Sep 29, 2025

Share Statistics

Current Share Class	469.91M
Shares Outstanding	n/a
Shares Change (YoY)	-0.45%
Shares Change (QoQ)	-0.09%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	40.24%
Float	453.49M

Valuation Ratios

The trailing PE ratio is 19.84.

PE Ratio	19.84
Forward PE	n/a
PS Ratio	1.91
PB Ratio	1.19
P/TBV Ratio	2.27
P/FCF Ratio	10.05
P/OCF Ratio	9.41
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.09, with an EV/FCF ratio of 9.59.

EV / Earnings	18.93
EV / Sales	1.89
EV / EBITDA	10.09
EV / EBIT	16.43
EV / FCF	9.59

Financial Position

The company has a current ratio of 2.99, with a Debt / Equity ratio of 0.16.

Current Ratio	2.99
Quick Ratio	2.28
Debt / Equity	0.16
Debt / EBITDA	1.38
Debt / FCF	1.36
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 6.06% and return on invested capital (ROIC) is 3.83%.

Return on Equity (ROE)	6.06%
Return on Assets (ROA)	3.44%
Return on Invested Capital (ROIC)	3.83%
Return on Capital Employed (ROCE)	6.32%
Revenue Per Employee	676,634
Profits Per Employee	65,149
Employee Count	4,287
Asset Turnover	0.48
Inventory Turnover	2.69

Taxes

In the past 12 months, FRA:ON4 has paid 48.18 million in taxes.

Income Tax	48.18M
Effective Tax Rate	14.71%

Stock Price Statistics

The stock price has increased by +11.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+11.22%
50-Day Moving Average	10.45
200-Day Moving Average	9.84
Relative Strength Index (RSI)	61.73
Average Volume (20 Days)	152

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:ON4 had revenue of EUR 2.90 billion and earned 279.29 million in profits. Earnings per share was 0.59.

Revenue	2.90B
Gross Profit	1.96B
Operating Income	333.93M
Pretax Income	327.51M
Net Income	279.29M
EBITDA	543.85M
EBIT	333.93M
Earnings Per Share (EPS)	0.59

Balance Sheet

The company has 1.05 billion in cash and 751.09 million in debt, giving a net cash position of 297.66 million.

Cash & Cash Equivalents	1.05B
Total Debt	751.09M
Net Cash	297.66M
Net Cash Per Share	n/a
Equity (Book Value)	4.68B
Book Value Per Share	9.88
Working Capital	1.61B

Cash Flow

In the last 12 months, operating cash flow was 589.17 million and capital expenditures -37.64 million, giving a free cash flow of 551.53 million.

Operating Cash Flow	589.17M
Capital Expenditures	-37.64M
Free Cash Flow	551.53M
FCF Per Share	n/a

Margins

Gross margin is 67.63%, with operating and profit margins of 11.51% and 9.63%.

Gross Margin	67.63%
Operating Margin	11.51%
Pretax Margin	11.29%
Profit Margin	9.63%
EBITDA Margin	18.75%
EBIT Margin	11.51%
FCF Margin	19.01%

Dividends & Yields

This stock pays an annual dividend of 0.47, which amounts to a dividend yield of 3.95%.

Dividend Per Share	0.47
Dividend Yield	3.95%
Dividend Growth (YoY)	-3.47%
Years of Dividend Growth	n/a
Payout Ratio	77.38%
Buyback Yield	0.45%
Shareholder Yield	4.40%
Earnings Yield	5.04%
FCF Yield	9.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:ON4 has an Altman Z-Score of 3.97 and a Piotroski F-Score of 5.

Altman Z-Score	3.97
Piotroski F-Score	5